Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise
beta
Latest Financials
Filings:
By Category
By Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
Company Exhibits:
Indentures
Material Contracts & Credit Agreements
Plans of Reorganization
Articles and Bylaws
Underwriting Agreements
SEC Edgar
AVON PRODUCTS INC
SIC 2844 · Perfumes, Cosmetics & Other Toilet Preparations
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
AVON PRODUCTS INC
SIC 2844 · Perfumes, Cosmetics & Other Toilet Preparations
Notes
Support
about
terms
Created by potrace 1.16, written by Peter Selinger 2001-2019
beatandraise.com
beta
Latest Financials
Filings:
Category
Date
Search Filings
Institutional Holders
beta
Earnings Transcripts
beta
Global Search
SEC Edgar
AVON PRODUCTS INC
SIC 2844 · Perfumes, Cosmetics & Other Toilet Preparations
Notes
Support
about
terms
AVON PRODUCTS INC
CIK:
0000008868
|
SEC Filings
Income Statement
Cash Flow
Balance Sheet
v3.23.1
Consolidated Statements of Operations - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Income Statement [Abstract]
Net sales
$ 550.0
$ 631.4
Other revenue
26.8
28.2
Revenue from affiliates of Natura &Co
13.7
3.7
Total revenue
590.5
663.3
Costs, expenses and other:
Cost of sales
(225.0)
(287.4)
Cost of sales from affiliates of Natura &Co
(13.4)
(4.2)
Selling, general and administrative expenses
(386.8)
(433.9)
Impairment of goodwill
(9.1)
0.0
Operating loss
(43.8)
(62.2)
Interest expense
(7.2)
(13.0)
Interest expense on Loan from affiliates of Natura &Co
(38.0)
(15.3)
Interest income
5.3
0.9
Interest income from affiliates of Natura &Co
1.6
0.7
Other income (expense), net
1.6
4.5
Total other expenses
(36.7)
(22.2)
Loss from continuing operations, before income taxes
(80.5)
(84.4)
Income taxes
(12.0)
(4.8)
Loss from continuing operations, net of tax
(92.5)
(89.2)
Loss from discontinued operations, net of tax
(27.4)
(7.8)
Net loss
(119.9)
(97.0)
Net loss attributable to noncontrolling interests
(0.1)
(0.2)
Net loss attributable to Avon
$ (120.0)
$ (97.2)
v3.23.1
Consolidated Statements of Cash Flows - USD ($)
$ in Millions
3 Months Ended
Mar. 31, 2023
Mar. 31, 2022
Cash Flows from Operating Activities
Net loss
$ (119.9)
$ (97.0)
Loss from discontinued operations, net of tax
(27.4)
(7.8)
Loss from continuing operations, net of tax
(92.5)
(89.2)
Adjustments to reconcile net loss from continuing operations to net cash used by operating activities:
Depreciation
13.3
10.9
Amortization
4.7
4.8
Provision for doubtful accounts
10.2
14.1
Provision for obsolescence
4.2
6.4
Share-based compensation
4.2
2.4
Foreign exchange (gains) losses
(5.6)
(7.3)
Deferred income taxes
5.0
(2.5)
Impairment loss on assets
9.1
0.0
Other
3.1
(0.6)
Changes in assets and liabilities:
Accounts receivable
4.7
(20.6)
Inventories
(21.0)
(33.1)
Prepaid expenses and other
(49.7)
9.4
Accounts payable and accrued liabilities
(43.2)
(65.4)
Income and other taxes
(6.2)
3.2
Noncurrent assets and liabilities
25.9
(0.9)
Net cash used by operating activities of continuing operations
(133.8)
(168.4)
Cash Flows from Investing Activities
Capital expenditures
(15.7)
(13.6)
Proceeds from disposal of assets
0.3
2.7
Net cash used by investing activities of continuing operations
(15.4)
(10.9)
Cash Flows from Financing Activities
Debt, net (maturities of three months or less)
41.6
86.8
Proceeds from debt
30.2
68.6
Repayment of debt
(1.7)
(18.9)
Repayment of debt to affiliates of Natura &Co
(52.5)
(10.7)
Repayment of debt from affiliates of Natura &Co
38.2
11.7
Settlement of derivative contracts
0.0
1.3
Net cash provided by financing activities of continuing operations
55.8
138.8
Net cash used by operating activities of discontinued operations
(24.6)
(5.6)
Net cash used by discontinued operations
(24.6)
(5.6)
Effect of exchange rate changes on cash and cash equivalents, and restricted cash
(5.1)
3.1
Net (decrease) increase in cash and cash equivalents, and restricted cash
(123.1)
(43.0)
Cash and cash equivalents, and restricted cash at beginning of period
367.9
251.5
Cash and cash equivalents, and restricted cash at end of period
$ 244.8
$ 208.5
v3.23.1
Consolidated Balance Sheets - USD ($)
$ in Millions
Mar. 31, 2023
Dec. 31, 2022
Current Assets
Cash and cash equivalents
$ 244.5
$ 367.6
Restricted cash
0.3
0.3
Accounts receivable, net
168.4
183.4
Receivables from affiliates of Natura &Co
88.6
72.9
Loans to affiliates of Natura &Co
93.9
72.2
Inventories
351.9
332.2
Prepaid expenses and other
169.2
127.9
Current assets of discontinued operations
0.0
1.8
Total current assets
1,116.8
1,158.3
Property, plant and equipment, at cost
890.6
881.1
Less accumulated depreciation
(566.8)
(548.1)
Property, plant and equipment, net
323.8
333.0
Right-of-use assets
87.8
92.1
Goodwill
18.5
25.9
Deferred tax asset
49.3
52.1
Loans to affiliates of Natura &Co
50.3
54.8
Other assets
427.9
445.5
Total assets
2,074.4
2,161.7
Current Liabilities
Debt maturing within one year
45.4
5.7
Loans from affiliates of Natura &Co
599.4
537.2
Accounts payable
433.1
461.5
Payables to affiliates of Natura &Co
57.8
58.1
Accrued compensation
66.7
77.2
Other accrued liabilities
217.9
247.4
Sales taxes and taxes other than income
68.7
67.9
Income taxes
9.6
5.2
Current liabilities of discontinued operations
81.0
79.9
Total current liabilities
1,579.6
1,540.1
Long-term debt
214.9
214.8
Loans from affiliates of Natura &Co
1,437.5
1,427.2
Long-term operating lease liability
67.4
71.5
Employee benefit plans
58.6
58.1
Long-term income taxes
28.1
33.0
Other liabilities
53.6
58.2
Total liabilities
3,439.7
3,402.9
Shareholders’ Deficit
Common stock - par value $0.01 per share - 101.34 outstanding at each period end
0.0
0.0
Additional paid-in capital
643.9
639.8
Retained earnings
(952.3)
(832.3)
Accumulated other comprehensive loss
(1,060.5)
(1,052.2)
Total Avon shareholders’ deficit
(1,368.9)
(1,244.7)
Noncontrolling interests
3.6
3.5
Total shareholders’ deficit
(1,365.3)
(1,241.2)
Total liabilities and shareholders’ deficit
$ 2,074.4
$ 2,161.7